Session(s)
- PBI-4050 Is Safe and Well Tolerat...
Monday, May 22 10:30 AM - 10:45 AM - P1272 PBI-4425, a Novel First-in-C...
Tuesday, May 23 9:15 AM - 4:15 PM - P1272 PBI-4425, a Novel First-in-C...
Tuesday, May 23 9:15 AM - 4:15 PM - P1272 PBI-4425, a Novel First-in-C...
Tuesday, May 23 9:15 AM - 4:15 PM - P17 PBI-4425, a Novel First-in-Cla...
Tuesday, May 23 9:15 AM - 4:15 PM - P17 PBI-4425, a Novel First-in-Cla...
Tuesday, May 23 9:15 AM - 4:15 PM - 916 PBI-4050 Reduces Expression of...
Wednesday, May 24 9:15 AM - 11:15 AM - 916 PBI-4050 Reduces Expression of...
Wednesday, May 24 9:15 AM - 11:15 AM - 812 Oral Treatment with PBI-4050 R...
Wednesday, May 24 1:30 PM - 3:30 PM - 812 Oral Treatment with PBI-4050 R...
Wednesday, May 24 1:30 PM - 3:30 PM - 812 Oral Treatment with PBI-4050 R...
Wednesday, May 24 1:30 PM - 3:30 PM - 813 Plasminogen Reduces Acute Lung...
Wednesday, May 24 1:30 PM - 3:30 PM - 813 Plasminogen Reduces Acute Lung...
Wednesday, May 24 1:30 PM - 3:30 PM - 813 Plasminogen Reduces Acute Lung...
Wednesday, May 24 1:30 PM - 3:30 PM